Chapters

Transcript

Video

What outcomes was the LEADER trial powered to assess? Can you specifically discuss the secondary microvascular outcomes in the kidney?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Johannes F.E. Mann, MD

Johannes F.E. Mann, MD

Professor of Medicine
University of Erlangen-Nürnberg
Director, Dept. of Nephrology, Hypertension & Rheumatology
Munich General Hospitals
Munich, Germany